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Abstract
The synthetic met-enkephalin syndyphalin-33 (SD-33) increases feed intake
in sheep and recently-weaned pigs. An experiment focused on changes in
hypothalamic levels of mRNA transcripts from the following genes: µ-opioid
receptor (MOR), neuropeptide Y (NPY), orexin (hypocretin; HCRT), melanocortin 4
receptor (MC4R), and agouti-related protein (AGRP). There was no effect of
treatment on BW or FI at any point in the study. There is a strong positive
correlation (p <0.001) between MOR and MC4 that remains regardless of treatment
or time. Weaning resulted in a numerical increase in hypothalamic MOR mRNA
expression. There was a treatment effect of MOR expression levels 4 days
postweaning. Hypothalamic NPY expression was unchanged through time or
treatment. In VEH pigs, weaning resulted in increased hypothalamic expression of
the HCRT gene at d 1 and d 7 postweaning (P(time) < 0.01). In SD pigs, an increase in
HCRT expression (relative to d 0) was observed at d 4 postweaning. Expression of
HCRT did not significantly differ between treatment groups at d 1 and d 4, but
HCRT expression was greater in VEH pigs than in SD pigs at d 7 (P(time x treatment) <
0.05). Expression of hypothalamic MC4R did not change through time, but a trend
(P(treatment) = 0.07) was observed such that expression was less in SD pigs than in
VEH pigs on d 1 and d 4 postweaning, possibly due to a numerical increase in
expression in VEH pigs on d 1 relative to d 0.
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Expression of AGRP was decreased 1 d postweaning in VEH pigs but not in SD
pigs,. On d 4, levels of AGRP expression were lower in SD pigs than in VEH pigs,
and lower than d 0 levels as well. On d7, AGRP expression was less in VEH pigs
than in SD pigs (P(time

x treatment)

<

0.01). Syndyphalin-33 has the potential to

alleviate the negative effects of stress during weaning, and has the potential to
increase feed intake through the melanocortinergic pathway. Further investigation
is needed to more fully elucidate the complex mechanisms by which syndyphalin-33
may act to abrogate the post-weaning growth lag in pigs.
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Introduction
Syndyphalin-33

(SD-33;

Tyr-D-Met(O)-Gly-N-methylphenethylamide)

is

a

synthetic enkephalin with prolonged analgesic activity (Kiso et al., 1981). In pigs,
rats, and sheep, administration of SD-33 via oral, subcutaneous, or intravenous
routes resulted in transient increases in circulating concentrations of growth
hormone (GH; Buonomo et al., 1991). Recently, SD-33 was found to increase feed
intake in adult sheep 48 h after intravenous administration, but this effect was lost
when the animals were challenged with lipopolysacharide (LPS; Obese et al., 2007).
In all three studies, the effects of SD-33 relating to analgesia, circulating GH
concentrations, and appetite were all blocked by naloxone, suggesting that they
were mediated at least in part through the -opiate receptor. The discrepancy in
the timing of effects (immediate analgesia and stimulation of GH, but 48 h before
significant increases in feed intake) is not yet understood.
The recently-weaned pig often exhibits decreased feed intake, increased
susceptibility to disease, and poor growth (Matteri et al., 2000; Kojima et al., 2007;
Kojima et al., 2008). This post-weaning growth lag can be manifested as mortality,
particularly in conditions of suboptimal herd health or management. Many factors
may determine the severity and duration of the post-weaning lag; evidence suggests
that weaning weight may modulate the expression of key regulators of appetite
during this period (Kojima et al., 2007).
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Preliminary data in our lab suggests that a single intramuscular injection of
syndyphalin-33 can increase feed intake in the recently-weaned pig (Kojima et al.,
submitted). SD-33 may offer some protection during the weaning process,
compensating for an extreme decrease in appetite, and increasing overall health
and well being of the animal during this critical period.
As an opioid molecule, SD-33 likely influences the regulation of expression of
many appetite-regulating genes. An experiment was conducted to investigate the
potential for SD-33 to alter hypothalamic expression of key appetite-regulating
genes during the first 7 d postweaning. The experiment focused on changes in
hypothalamic levels of mRNA transcripts from the following genes: µ-opiate
receptor (MOR), neuropeptide Y (NPY), orexin (hypocretin; HCRT), melanocortin 4
receptor (MC4R), and agouti-related protein (AGRP).
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Literature Review
Syndyphalin-33
Syndyphalin-33 (SD-33; Tyr-D-Met(O)–Gly-N-methylphenethylamide) was first
synthesized in 1981 by scientists at the University of Tokushima, Japan (Kiso et al.,
1981). A tripeptide, SD-33 represents the ―minimal segment‖ of Met-enkephalin (an
endogenous opioid peptide) that exhibits prolonged analgesic activity (Baulieu and
Kelly, 1990). To evaluate the similarity of SD-33 to morphine, another opioid
compound known for its analgesic properties, the authors conducted a tail-flick test
in mice. A single subcutaneous injection of SD-33 was administered at 2, 4 and 8
mg/kg, doses comparable to 1, 2 and 4 mg/kg injections of morphine, respectively.
The tail-flight response (in seconds) was recorded over a period of 180 minutes. SD33 was similar to morphine in both the potency and duration of analgesia. The
authors believed that although SD-33 no longer resembled an enkephalin, its ability
to be stable in the mouse model made it a valuable opioid peptide.
Buonomo and colleagues evaluated the effect of syndyphalin-33 on the release of
growth hormone in sheep, pigs and rats (Buonomo et al., 1991). Sheep were injected
intravenously with SD-33 in a dose of .05, .10 and .20 µmol/kg. As compared to
controls, GH (measured in ng/ML) was elevated in all groups five minutes after i.v.
injection and remained elevated for 45 minutes. When sheep were given the i.v.
injections two hours apart, SD-33 treated animals again had significantly higher
GH levels than did control animals. Rats and 40-kg pigs were given a single
3

subcutaneous injection of 0.0, 0.50, 1.0 and 2.0 µmol/kg or 0.0 or 0.50 µmol/kg SD33, respectivel. Plasma GH concentrations were elevated in treated pigs relative to
controls in a dose dependent manner, peaking at 30 minutes postinjection and
remaining elevated at 60 minutes postinjection. Rats were given an oral gavage of
SD-33 in a dose of 0.0, 1.0, 10.0 or 100.0 µmol/kg. An increased in GH levels was
observed within 15 minutes, and for the rats given the dose of 100.0 µmol/kg,
remained elevated for 2 hours post-administration. Pigs were given an oral gavage
of SD-33 in a dose of 0.0, 0.125, 0.50 or 2.0 µmol/kg. The GH levels were elevated for
all treatment groups relative to controls within 30 minutes of administration and
remained elevated for two hours. To determine if SD-33 was actually working
through the - opiate receptor, the authors challenged rats with both SD-33 and the
opioid antagonist naloxone. Naloxone was able to completely block the elevation of
GH concentrations by SD-33 at both the 1.0 and 10.0 mg/kg dose.
In 2007, Obese and others evaluated the effect of syndyphalin-33 on long-term
feed intake in sheep (Obese et al., 2007). Three experiments were performed. Sheep
were given an intravenous injection of SD-33 at a dose of 0.0, 0.05 or 0.1 µmol/kg.
Feed intake was measured for 48 hours. Feed intake at 24 hours was greater in
sheep receiving 0.1 µmol/kg dose of SD-33 relative to controls. After 48 hours, both
the 0.1 and 0.05 µmol/kg groups had eaten significantly more feed than the control
group. The next experiment tested the ability of naloxone to block the effects of SD33. Naloxone was effective in blocking the stimulatory effect of SD-33 on feed
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intake. Lastly, sheep were given either saline or SD-33 in conjunction with or
without an immune challenge in the form of lipopolysaccharide (LPS. There was no
difference in intake in LPS-challenged sheep with or without SD-33: although SD33 increased the feed intake of adult sheep, it did not counteract the decrease in FI
associated with an immune challenge.
Weaning
Currently, pigs are weaned (separated from the dam) at approximately 21 days
of age, depending on the particular management practices of the facility (Holden
and Ensminger, 2006). The stress of weaning causes reduced weight gain or actual
weight loss directly after weaning. In addition to the stress of being separated from
the dam, change to an unfamiliar food source and an unfamiliar way of obtaining
that food also lead to weight loss (Libbrandt et al., 1975; Bark et al., 1986). The age,
weight, and sex of the animal are all factors contributing to how severely the animal
is affected by the stressors of weaning (Libbrandt et al., 1975; Cooper et al., 2009).
Weaning also causes the animal to become immunosupressed (Kojima et al., 2008).
There is an increase in somatotropin (GH) concentrations and a decrease in IGF-I
and IGF-II (Carroll et al., 1998; Matteri et al., 2000). After weaning, there is
increased plasma and urinary levels of cortisol concentrations as well as decreased
plasma corticosteroid-binding globulin (Le Dividich and Seve, 2000; Heo et al., 2003;
Kojima et al., 2008). Factors such as weaning weight and sex also attribute to the
immune status of the piglet (Matteri et al., 2000; Bruininx et al., 2001; Kojima et
5

al., 2007; Cooper et al., 2009). Mortality rate in the nursery phase (defined as the
period from weaning to 60 lbs.) was 2.9% in 2006 (USDA, 2008). The causes of death
are listed in table 1.
Appetite
The regulation of appetite is important in maintaining energy balance in the
body. The role of the hypothalamus in appetite has been extensively reviewed by
Arora and Anubhuti (2006). The hypothalamus can be broken down into several
regions, or ―nucleii‖. The arcuate nucleus controls the body’s energy balance and is
the feeding control center, integrating various hormonal signals (Funahashi et al.,
2000). The arcuate nucleus produces neuronal peptides such as Neuropetide Y
(NPY), Agouti-related protein (AGRP) and

-melanocyte stimulating hormone ( -

MSH; Arora and Anubhuti 2006). The paraventricular nucleus integrates signals
from the thyroid and the hypothalamic-pituitary axis involved in nutrition. Some of
the neuronal pathways that communicate between the two include NPY, orexin,
and -MSH (Neary et al., 2004). The ventromedial nucleus of the hypothalamus is a
target for leptin and acts as a center for controlling satiety (Satoh et al., 1997). The
dorsomedial hypothalamic area processes information from other areas of the
hypothalamus such as the medial and lateral hypothalamic nuclei, and also
produces orexins (Elmquist et al., 1998). In addition, the lateral hypothalamic area
contains glucose-sensitive neurons that help regulate feeding and produces orexins
(Bernardis et al., 1996). The brain stem includes the nucleus of tractus solitaries
6

(NTC). The NTC contains a high number of NPY-binding sites, and controls the
frequency of meals as well as the size of meals, and gives fullness signals once the
meal is complete (Harfstrand et al., 1986; Kawai et al., 1984; Williams et al., 2001).
A schematic representation of each area of the hypothalamus and the hypothalamic
and peripheral neuropeptides associated with each is shown in figure 1.
Opioids and Opioid Receptors
The body produces endogenous opioids that can be classified into three families.
Each family of ligands is produced by a single gene. These genes are the
proopiomelanocortin, proenkephalin and prodynorphin genes (Akil et al., 1984).
There are three classical opioid receptor types: mu (µ), kappa (k), and delta ( ). All
three of the opioidreceptor subtypes are involved in analgesia (Zöllner and Stein,
2007). Synthetic opioids such as morphine can also bind to the opiate receptors and
have similar effects to endogenous opioids (Kiso et al., 1981).
An extensive review by Bodnar (2004) describes how endogenous opioids affect
feeding behavior and appetite. Agonists of all three opioid receptor types have been
shown to increase feed intake (Lowy et al., 1983; Gosnell et al., 1986). The route by
which these effects occur can be through changes in transcription and/or activity of
AGRP, NPY, peptide YY and the melanocortin 3 and 4 receptors (Olszewski et al.,
2001; Kotz et al., 1993; Hagan et al., 1993; Grossman et al., 2003). According to
Glass (1999), opioids produced in different parts of the brain cause differing types of
food responses. Opioids in the hindbrain are classified as sensory and metabolic in
7

nature, whereas opioids associated with the amygdala regulate the emotional
response to food, and opioids in the hypothalamus are associated with maintaining
homeostasis (Glass et al., 1999). The effect that opioids have on the appetite
pathway can change depending on the energy needs of the animal (Margules et al.,
1978).
Effects of stress and opiates on µ-opioid receptor expression
During stress, the body will release endogenous opioids, and decrease the
number of available opioid receptors through negative feedback mechanisms
(Seeger et al., 1984). In some cases however, stress can increase expression of the µopioid receptor, as was observed in young rats experiencing stress due to hot plate
exposure (Torda et al., 1978). In the hypothalamus of these rats, the numbers of
opiate receptor sites were significantly higher than controls. The authors speculated
that stressing the young underdeveloped brain of these animals led to the
development of an over-functioning defense system.
Effects of Stress and Opioids on Specific Appetite Regulators
Neuropeptide Y (NPY) is a 36 amino acid hypothalamic peptide that exhibits
appetite-stimulating activity (Tatemoto et al., 1982; Billington et al., 1991). The
mRNA expression of NPY increased in the arcuate nucleus of the hypothalamus in
rats when deprived of food and during periods of food restriction. The change in
NPY mRNA expression was most notable in the male rats as compared to females
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in this particular study (Brady et al., 1990). Hypothalamic NPY gene expression
was 88% higher in ewe lambs that were nutrient-deprived as compared to lambs
that were adequately nourished (McShane et al., 1993). The weanling pig produces
NPY in a body weight-dependent manner, such that pigs with greater weaning
weights have increased NPY mRNA levels 4 days postweaning (Kojima et al., 2007).
Stress will alter the expression of NPY: when rats are stressed, they exhibit
increased expression of NPY in the arcuate nucleus (Makino et al., 2000). Appetite
is stimulated by µ-opioid agonists through up-regulating activity of NPY (Kotz et
al., 1993; Pomonis et al., 1997; Dodo et al., 2005). Rats that were injected
simultaneously with NPY and a

- and

-opioid receptor antagonist showed

decreased feed intake while the same injections with a -opioid receptor antagonist
showed no effect on feed intake (Kotz et al., 1993). In male rats, the increase in feed
intake caused by the injection of NPY directly into the paraventricular nucleus
could be blocked with naloxone (Pomonis et al., 1997). In male broiler chicks, a
similar study was performed to investigate the effects of -, - and -opioid receptor
antagonists on NPY-induced feeding. In agreement with Kotz et al. (1993), the most
dramatic effects were seen when the -opioid receptor antagonist was administered
(Dodo et al., 2005). These studies indicate that the -opioid receptor in particular,
and possibly others, is effecting NPY-induced feeding.
The hypocretin or prepro-orexin gene produces two products, orexin-A and
orexin-B. While only 46% similar in amino acid sequence, both orexin-A and orexin-
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B will stimulate feed intake when administered directly into the hypothalamus of
rats (Sakurai et al., 1998). Also, the mRNA of these peptides is up-regulated when
rats are fasted, indicating their role in the appetite pathway (Sakurai et al., 1998).
Increased feed intake has also been observed in pigs when given an intramuscular
injection of orexin-B (Dyer et al., 1999), and in sheep when given orexin-B
intravenously (Sartin et al., 2001). The weanling pig produces orexin in a body
weight dependent manner, such that pigs with grater weaning weights have greater
mRNA levels of orexin 4 days postweaning (Kojima et al., 2007). Stress can affect
orexin production: immobilization stress in young rats will increase mRNA
expression levels of orexin (Ida et al., 2000). The administration of morphine in mice
depressed the hyprocretin/orexin arousal system (Li et al., 2008).
The melanocortin 4 receptor (MC4R), one of five melanocortin receptors. is a G
protein-coupled receptor found throughout the central nervous system. Opioiods will
decrease

expression

of

the

MC4R

gene

Proopiomelanocortin (POMC) gene products

(Chaki

et

al.,

2005).

The

-MSHia an MC4R agonist, while

agouti-related protein (AGRP) is an MC4R antagonist (Cone, 2005). When -MSH is
bound to MC4R there is an appetite-suppressing effect on feed intake; this effect
can be blocked by the antagonist AGRP (Kalra et al., 1999). Agouti-related protein
is a neuropeptide produced by the same neurons of the hypothalamus that produce
NPY and has potent appetite stimulating properties that are long lasting (Shutter
et al., 1997; Ollmann et al., 1997). Outside of the melanocrotin pathway, the variant
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AGRP-(18-132) has long lasting orexinogenic effects that may involve the regulation
of as yet unidentified gene products at transcriptional, translational and/or posttranslational levels (Hagan et al., 2000). Pigs with heavier weaning weights have
greater levels of hypothalamic AGRP mRNA 4 days postweaning when compared to
pigs with lighter weaning weights (Kojima et al., 2007). Stress will effect the
interactions between MC4R, AGRP, and

-MSH (collectively known as the

melanocortin system). In rats, AGRP mRNA expression in the arcuate nucleus is
decreased following a stressful event, contributing to increased sensitivity for

-

MSH and subsequent decreased feed intake (Kas et al., 2005). Forced swimming
and restraint in rats increased POMC gene expression and suppressed feeding, but
pretreatment with an MC4R antagonist blocked the anorectic and anxiogenic effects
of these stressors, suggesting that the melanocortinergic pathway is heavily
involved in stress-related anorexia (Liu, 2007).
A model using opiate administration to alleviate stress has been investigated in
infant Rhesus monkeys. Opiate administration was found to be an effective method
of elevating separation-induced stress in these animals (Kalin et al., 1988).
Administration of morphine and fentanyl (both µ-opioid receptor agonists) during a
surgical procedure resulted in decreased postoperative cortisol concentrations
relative to controls in young (20 kg) pigs (Malavasi et al., 2006), but it is unclear if
this was due to a direct effect of the opioids or a response to differing levels of postoperative pain (an indirect effect due to the analgesic properties of the opioids).
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Conclusions
The appetite pathway is disrupted by the stress of weaning in the young pig.
Opiates may represent a novel mechanism to ease the stress of weaning, increase
feed intake, and increase overall production gains. The following experiment
explores the effects of the synthetic opioid syndyphalin-33 on weaning stress and
appetite regulators in the pig.
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Materials and Methods
All animal procedures were reviewed and approved by the University of
Tennessee Animal Care and Use Committee.
Animals and diets
Crossbred pigs (Landrace X Duroc X Hampshire) were farrowed in standard
farrowing pens and processed according to usual University of Tennessee
Experiment Station practice between 4 and 7 d of age. Standard processing
procedures included needle teeth clipping, tail docking, iron supplementation, ear
tagging, and castration of males. Piglets were kept in farrowing pens with their
dams until weaning, with creep feed (Diet 554PE, Tennessee Farmers Cooperative,
La Vergne, TN) available after 7 d of age.
Experimental Design
On day 0 (weaning day), 77 pigs (barrows and gilts, 19 + 3 d of age, 7.16 + 1.03
kg, 3 replications) were removed from the dam, weighed and allocated into four time
groups: d 0 (weaning day), and d 1, 4 and 7 (postweaning). Tissue samples were
collected on d 0 from unweaned animals (n = 19) and were considered a pre-weaning
baseline. The remaining groups were further allocated into the following treatment
groups: SD, receiving 0.5 µmole/kg SD-33 in a single intramuscular injection of 0.5
mL or less of saline; or VEH, receiving a single intramuscular injection of 0.5 mL
saline. After administration of treatments, animals were weaned into individual
pens (1.3 m2) with nursery feed and water provided ad libitum. Body weight and
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feed intake measurements were taken on d 1, 4 and 7 post-weaning, and average
daily feed intake was calculated for each interval. Tissue samples were collected on
d 1, 4 and 7 on animals within each treatment group (n = 8 or 9).
Tissue Collection and Processing
Animals were humanely euthanized and the hypothalamus was collected as
previously described (Kojima et al., 2007) and stored in 5 mL RNAlater solution
(Ambion, Forest City, CA) at -20°C until processed. For the isolation of mRNA from
hypothalamus, tissue samples were homogenized in 10-20 volumes of TRI Reagent
Solution (Ambion, Foster City, CA) and allowed to incubate for 5 minutes. After
homogenization, bromochloropropane and isopropanol were used to extract total
mRNA. Samples were then washed with ethanol and suspended in RNAse-free
water. To remove DNA contamination, samples were incubated with DNAse using
the Turbo DNA-Free kit (Ambion, Forest City, CA).

Reverse transcription was

performed with the High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Forest City, CA) as per manufacturer recommendations.

All cDNA

samples were characterized (concentration and 260/280 nm absorbance ratio) and
stored at -20°C until gene expression analysis was performed.
Gene Expression Analysis
Gene expression in the hypothalamus was analyzed using the quantitative realtime polymerase chain reaction technique with the following parameters: 2 min at
50°C, 8.5 min at 95°C, 45 cycles of 15 sec at 95°C followed by 1 min at 60°C,
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indefinite hold at 4°C. For each gene of interest, primer efficiency was determined
using a dilution series as described by Pfaffl (2001). In each reaction, a total volume
of 20 µl was used including 10 µl Applied Biosystems Gene Expression Master Mix
(Forest City, CA), 7 µl water, 2 µl cDNA template, and 1 µl Taqman Gene
Expression assay primer/probe mix (Applied Biosystems, Forest City, CA). Table 1
shows the primer and probe sequences, efficiency and amount of cDNA used for
each gene of interest. Threshold values were chosen so that data points were
measured in the log section of the fluorescence curve. Each sample was run in
duplicate, with the final CT value being the average of both readings. The selected
internal reference was 18S rRNA, and all target genes were normalized to it by
calculating ΔCT. The ΔCT value was then transformed linearly as described by Livak
and Schmittgen (2001) to obtain a relative expression value.
Statistical Analyses
Variables were analyzed in SAS using mixed model analysis of variance. Log
transformations were performed on gene expression variables to maintain
homogeneity of variance. Pig was the experimental unit. Body weight and daily feed
intake were analyzed with repeated measures. Correlations and their associated
values were analyzed for relationships among pre-weaning body weight and
appetite genes both pre-weaning and 24 hours post weaning. A scatter plot and
related correlation value were obtained for MC4R and MOR over all treatment
groups. Gene expression data was analyzed with time and treatment as main effects

15

and the interaction between the two factors was also evaluated. Least squares
means were compared using Fisher’s protected least significant difference. A
significance level of P < 0.05 was used for all testing; trends were reported if P <
0.10. Preliminary analysis detected no replicate effect, and so replicate was removed
from the model. Pre-weaning body weight and sex were evaluated as covariates and
were found to have no effect and were removed from the model. All figures depict
raw means and standard errors.
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Results
Feed Intake and Body Weight
As expected, average daily feed intake in VEH and SD pigs was minimal during
the first 24 h post-weaning (Figure 2). Increases in average daily feed intake were
evident for both treatment groups when measured from d 1 to d 4, and from d 4 to d
7, relative to the previous interval (P < 0.05). No significant difference in average
daily feed intake due to treatment was observed at any time. Body weighs of pigs in
both treatment groups remained unchanged 1 d postweaning relative to d 0 weights
(Figure 3). Similar to what was seen in average daily gain, increases in body weight
were evident for both treatment groups when measured from d 1 to d 4, and from d
4 to d 7, relative to the previous interval (P < 0.05). No significant difference in body
weight due to treatment was observed at any time.
Gene Expression
Weaning resulted in a numerical increase in hypothalamic MOR mRNA
expression on d 1 and d 4 post-weaning in VEH pigs such that on d 4, MOR
expression was significantly greater in VEH pigs than in SD pigs (P < 0.05; Figure
4). There was no difference between MOR expression levels in SD pigs at any time,
although a numerical decrease in expression at d 4 contributed to the difference in
expression observed between treatment groups at that time (P(time x treatment) = 0.01).
Expression of MOR at d 7 did not differ between treatment groups or from pre-wean
levels.
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Hypothalamic NPY expression was unchanged through time or treatment, but a
trend (P(time x treatment) = 0.07) was observed such that while NPY expression was less
in SD than VEH pigs at d 1 and d 4 postweaning, expression was greater in SD pigs
compared to VEH pigs at d 7 (Figure 5).
In VEH pigs, weaning resulted in increased hypothalamic expression of the
HCRT gene at d 1 and d 7 postweaning relative to pre-wean levels (P(time) < 0.01;
Figure 6). In SD pigs, an increase in HCRT expression (relative to d 0) was observed
at d 4 postweaning. Expression of HCRT did not significantly differ between
treatment groups at d 1 and d 4, but HCRT expression was greater in VEH pigs
than in SD pigs at d 7 (P(time x treatment) < 0.05).
Expression of hypothalamic MC4R did not change through time, but a trend
(P(treatment) = 0.07) was observed such that expression was less in SD pigs than in
VEH pigs on d 1 and d 4 postweaning, possibly due to a numerical increase in
expression in VEH pigs on d 1 relative to d 0 (Figure 7). Levels of expression of
MC4R were not different from d0 levels in either treatment group at d4 or d7 postweaning.
Expression of AGRP was decreased 1 d postweaning in VEH pigs but not in SD
pigs, relative to d 0 (Figure 8). On d 4, levels of AGRP expression were lower in SD
pigs than in VEH pigs, and lower than d 0 levels as well. On d7, AGRP expression
was less in VEH pigs than in SD pigs at that time, and less than prewean levels as
well (P(time x treatment) < 0.01).
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Correlations
Relationships between body weight and expression of appetite genes at d 0
(pre-weaning) were evaluated (Table 3). Body weight was positively associated with
MC4R expression (r = 0.544; p = 0.0146), and tended to be positively associated with
MOR expression (r = 0.404; p = 0.0865). A strong positive correlation (r 0.801; p <
0.0001) existed between MC4R and MOR. Expession of NPY tended to be positively
correlated with MC4R expression (r = 0.418; p = 0.0753), and was positively
associated with MOR expression (r = 0.694; p = 0.0006). Expression of HCRT was
found to be positively associated with AGRP expression (r = 0.818; p < 0.0001).
Correlations between transcript abundance of appetie genes was assessed at
1 d postweaning were also evaluated (Table 4). A positive relationship between
expression of MC4R and MOR was observed at 1 d postweaning (r = 0.515; p =
0.0333), and a trend where MC4R and NPY expression were positively associated
was also noted (r = 0.421; p = 0.0930). There was a strong positive correlation (r =
0.764; p = 0.0002) between expression of MC4R and HCRT. Additionally, positive
relationships were also observed between MOR and NPY expression (r = 0.612; p =
0.0077) and between HCRT and AGRP expression (r = 0.604; p = 0.0051).
A strong positive correlaton between expression of MOR and MC4R existed
across time and treatment (r = 0..665; p < 0.001; Figure 9).
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Discussion
Inhibition of piglet growth rate caused by weaning is well recognized and clearly
associated with reduced feed intake (Bark et al., 1986; McCracken et al., 1995). In
this experiment, weaning resulted in low feed intake and no weight gain over the
first day postweaning, but pigs recovered so that both average daily feed intake and
body weights were greater by d 4 and were still increasing by d 7. We did not
observe an increase in average daily feed intake or body weight due to treatment
with syndyphalin-33, although feed intake was numerically higher in SD animals
after d 1. In a previous study in which pigs were given syndyphalin-33 then weaned
into group pens, cumulative feed intake did not significantly increase (relative to
intake of controls) until 9 d postweaning (Kojima et al., submitted). Obese et al.
(2007) observed an increase in feed intake 48 h postinjection in adult wethers
injected i.v. with SD-33 at a dosage of 0.05 mmole/kg. Differences in the timing of
response may arise due to differences in age, species, route of administration,
dosage, and level of concurrent stress. It should be noted that in both growing pigs
(50 kg barrows; Buonomo et al., 1991) and recently-weaned pigs (Kojima et al.,
submitted), a single injection of SD-33 at 0.5 µmole/kg resulted in similar increases
in circulating growth hormone. The mechanism behind the prolonged, cumulative
effect on feed intake is unclear. The actions of SD-33 on regulation of hypothalamic
gene expression may occur much earlier than when the actual outcome (increased
feed intake) is observed.
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The stress of weaning numerically increased expression of the µ-opiate receptor
in VEH pigs on d 1 and d4, but this was not evident in SD pigs; indeed, by d 4 the
difference in expression levels between VEH and SD pigs was significant. While
there is some evidence that stress (and subsequent release of endogenous opioids)
would predict a down-regulation of the opiate receptors (Seeger et al., 1984), this
response may be dependent on age. In young rats experiencing stress due to hot
plate exposure, opiate receptor levels in the hypothalamus were significantly higher
in the stressed animals as compared to controls. It was speculated that by stressing
the young underdeveloped brain of these animals, the development of an over
functioning defense system arose (Torda et al., 1978). Obese et al. (2007) observed
that the increase in feed intake in adult wethers by SD-33 was blocked by naloxone,
suggesting that the effect was mediated (at least in part) through µ-opiate
receptors. In the present study, a down-regulation of hypothalamic MOR expression
was observed in SD pigs relative to VEH pigs at d 4, supporting the notion that SD33 binds the µ-opiate receptor as µ-opioids will readily down-regulate their
receptors by many different mechanisms, including modulation of gene expression
(Gach et al., 2008). It is impossible to say when the down-regulation first occurred,
although it is tempting to speculate that it had actually began prior to sample
collection at d 1, as evidenced by the numerical difference between treatment
groups at that time. By d 7, MOR expression in VEH pigs had decreased to its
lowest observed level while expression in SD pigs was no different from pre-wean
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levels, suggesting that homeostatic mechanisms may have been activated to
alleviate the effects of both weaning and SD-33 on MOR expression.
In the present study, a trend was observed where weaning tended to increase
expression of NPY in VEH pigs more than in SD pigs at d 1 and d 4 postweaning,
but NPY expression had decreased to pre-weaning levels by seven days postweaning
in those animals. The expression patterns of NPY during the weaning process in the
pig are largely unknown. Previously, we found that hypothalamic NPY mRNA
expression at 4 d postweaning was positively associated with weaning weight
(Kojima et al., 2007). When rats are stressed they also exhibit increased expression
of NPY in the arcuate nucleus (Makino et al., 2000). Expression of NPY in SD
animals did not appear to fluctuate over the course of the study. Opioid agonists
have been shown to stimulate feed intake by up-regulating activity of NPY (Kotz et
al., 1993; Pomonis et al., 1997; Dodo et al., 2005). It is possible that we missed
modulation of expression that occurred before or after the times we chose for tissue
collection. It is also unclear if the apparent increase in NPY expression in VEH pigs
is a consequence of stress or a response to hunger, as transcription activity of the
NPY gene will increase during fasting or feed-restriction (Shimokawa et al., 2003;
minor et al., 2009).
Orexin (hypocretin) will increase feed intake in pigs (Dyer et al., 1999) as well as
many other animals (as reviewed by Benoit et al., 2008). Similar to NPY, postweaning levels of HCRT expression are dependant to some extent on weaning
weight, such that heavier pigs have greater hypothalamic expression of HCRT
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(Kojima et al., 2007). A stressful event such as immobilization stress in young rats
will increase transcript abundance of HCRT (Ida et al., 2000). Here, the stress of
weaning increased HCRT expression at d 1 and d 7 postweaning in VEH pigs, but
not in SD pigs. Treatment with SD-33 may have resulted in the down-regulation of
HCRT expression; Li and van den Pol (2008) showed that exogenous opiates such as
morphine will depress the hyprocretin/orexin arousal system.
Stress, in particular electrical foot shock in rats, will increase expression of the
MC4R gene (Yamono et al., 2004). Opiates, on the other hand, will decrease
expression of MC4R (Chaki et al., 2005). This coincides with what was observed
when piglets where weaned and treated with SD-33. We observed an increase in
MC4R expression due to weaning 1 d after the piglet was removed from the sow, but
this increase was negated when the piglet received treatment with SD-33 at
weaning. By 4 d postweaning, MC4R expression had essentially returned to preweaning levels in both treatment groups.
Agouti-related protein is an MC4R antagonist (Cone, 2005) and will increase
feed intake (as reviewed by Pritchard and White, 2005). The stress of weaning
caused an increase in expression of AGRP on day one followed by a sharp decrease
in expression on day four followed by an increase by seven days post weaning. A
stressful event will decrease the expression of AGRP (Kas et al., 2005). Opiates
have been shown to increase activity of AGRP (Hagan et al., 2001). In the present
study, we also observed an increase in the expression of AGRP due to the effects of
an opiate.
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The (83-132) splice variant of AGRP has long lasting orexinogenic effects (Hagan
et al., 2000). We observed changes in AGRP and MC4R expression levels due to SD33 at 1 d postinjection, yet previous studies in sheep (Obese et al., 2007) and pigs
(Kojima et al., submitted) consistently describe a delayed response in feed intake.
Hagan et al. (2000) suggests that the prolonged effects of AGRP - (83-132) may stem
from its role in regulating transcription and synthesis of other proteins further
downstream in the appetite pathway. Interestingly, AGRP has also been shown to
increase

activity

at

opioid

receptors.

When

AGRP–

(82-132)

was

given

simultaneously with naloxone, the short-term orexinogenic affects of AGRP– (82132) were decreased, but the long-term effects were not altered (Hagan et al., 2001).
Although modulation of opioid action by AGRP – (82-132) appears to be of a short
duration, it may contribute to the overall effects of SD-33. It is important to note
that the primers we used for quantitating expression of AGRP were not designed to
be specific for a particular splice variant, and so any effect of SD-33 on AGRP – (82132) abundance is unkown.
Obese et al. (2007) observed that the increase in feed intake by SD-33 was
blocked by naloxone, suggesting that the effect was mediated through µ-opioid
receptors. Appetite is stimulated by µ-opiate agonists in many ways: by
upregulating activity of the appetite stimulators AGRP and NPY (Hagan et al.,
2001; Brugman et al., 2002) and by decreasing synthesis of the appetite suppressor
-melanocyte stimulating hormone ( -MSH), a product of the proopiomelanocortin
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(POMC) gene (Wardlaw et al., 1996). Opiates also act to decrease expression of the
MC4R gene, the product of which is the receptor which binds both

-MSH and

AGRP (Chaki et al., 2005). Stress also regulates the expression of many of these
regulators of appetite. Kas et al. (2005) observed that in rats, AGRP mRNA
expression in the arcuate nucleus is decreased following a stressful event,
contributing to increased sensitivity for

-MSH and subsequent decreased feed

intake. Liu et al. (2007) observed that forced swimming and restraint increased
POMC gene expression and suppressed feeding, but pretreatment with an MC4R
antagonist blocked the anorectic and anxiogenic effects of these stressors,
suggesting that the melanocortinergic pathway is heavily involved in stress-related
anorexia.
Several positive relationships were found to exist between body weight and the
expression of appetite-regulating genes prior to weaning. Body weight was
positively correlated with MC4R and MOR on d 0. But these become uncoupled at
24 h postweaning.
The positive relationships between MC4R and NPY, MOR and NPY, and HCRT
and AGRP remain through the first 24 hours of weaning. The positive relationship
between HCRT and MC4R becomes apparent 24 hours after weaning. This may be a
result of the stress of weaning, as stress has been shown to increase transcriptional
activity of both of these genes (Ida et al., 2000; Yamano et al., 2004). We observed a
strong correlation between MC4R and MOR expression across all time and
treatment, supporting the concept that the melanocortinergic pathway is influenced
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by opiod tone at all times. This is in agreement with Chaki et al. (2005) who
observed that opioids down-regulated MC4R expression. As an opioid agonist, SD33 would be expected to down-regulate transcription of its receptor as well as
MC4R, resulting in a positive association between the expression of those two
genes.
Opioid administration was found to be an effective method of elevating
separation-induced stress in infant rhesus monkeys separated from their mothers
(Kalin et al., 1988), and in speeding post-operative recovery (including recovery of
appetite) in young (20 kg) pigs (Malavasi et al., 2006). Similarly, the synthetic
enkephalin SD-33 also has the potential to alleviate the negative effects of stress
during weaning in pigs, and has the potential to increase feed intake through effects
on the melanocortinergic pathway. Further investigation is needed to more fully
elucidate the complex mechanisms by which syndyphalin-33 may act to abrogate
the post-weaning growth lag in pigs.
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Table 1. Percentage of Nursery Pig Deaths by Producer-identified Causes in 20061
Cause

%

Scours

12.5

1.1

Starvation

9.8

0.9

Respiratory Problems

44.2

2.3

CNS/Meningitis

18.7

1.9

Other identified problems

4.1

0.8

Unknown problem

10.7

1.1

Total

100

1 Adapted

Std. Error

from (USDA, 2008)
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Table 2. Details of primers and probes used for real-time PCR
Gene1

Forward Primer Sequence

Reverse Primer Sequence

Probe Sequence

18-S2
18-S3
18-S4
MC4R
MOR
NPY
HCRT
AGRP

GGCCTGCTTTGAACACTCTAATTTT
GGCCTGCTTTGAACACTCTAATTTT
GGCCTGCTTTGAACACTCTAATTTT
GTAATTCCATCATCGATCCCCTGAT
TGGTCTGCCTGTGATGTTCATG
TCGGCGTTGAGACATTACATCA
GGCCGGCATCCTCACT
GCAGGCCGAGGCCAA

CCCCTCGATGCTCTTAGCT
CCCCTCGATGCTCTTAGCT
CCCCTCGATGCTCTTAGCT
GGGATAGCAACAGATGATCTCTTTGA
GGTGAGAGAATGTTAGTGCACAATC
GTCTCGGGACTAGATCGTTTTCC
GCAGCCGGCCTTGCA
CGTGCCTTGCGTCCTTC

CCCCGCGGGACACT
CCCCGCGGGACACT
CCCCGCGGGACACT
CCGGAGCCAAGAACT
AACCATTCCGGTACTTTGT
CACCAGGCAGAGATAC
CCGCCGCTTGCCCA
CAGAGGTGCTAGATCCT

1MC4R

Efficiency
(%)
102
102
94
104
97
105
92
85

Concentration
(ng/µl)
25.00
1.00
10.00
25.00
25.00
1.00
1.00
10.00

= Melanocortin 4 Receptor; MOR= µ-Opiate Receptor; NPY = Neuropeptide Y; HCRT = Hypocretin;
AGRP = Agouti Related Protein.
2Used to normalize MC4R and MOR.
3Used to normalize NPY and HCRT.
4Used to normalize AGRP.
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Table 3. Correlations of messenger RNA expression of appetite regulators before
weaning.
Variables1
x
y

r

p-value

d 0 wt

MC4R

0.544

0.0146

d 0 wt

MOR

0.404

0.0865

d 0 wt

NPY

0.155

NS2

d 0 wt

HCRT

0.028

NS

d 0 wt

AGRP

-0.030

NS

MC4R

MOR

0.801

<0.0001

MC4R

NPY

0.418

0.0753

MC4R

HCRT

-0.133

NS

MC4R

AGRP

0.007

NS

MOR

NPY

0.694

0.0006

MOR

HCRT

-0.199

NS

MOR

AGRP

-0.153

NS

NPY

HCRT

-0.0231

NS

NPY

AGRP

-0.097

NS

HCRT

AGRP

0.818

<0.0001

d 0 wt= pre weaning body weight; MC4R= Melanocortin 4 Receptor; MOR= µOpiate Receptor; NPY= Neuropeptide Y; HCRT= Hypocretin/Orexin; AGRP= Agouti
Related Protein.
1

2

NS= not significant.

43

Table 4. Correlations of messenger RNA expression of appetite regulators 24 hours
after weaning.
x

Variables1
y

r

p-value

MC4R

MOR

0.515

0.0333

MC4R

NPY

0.421

0.0930

MC4R

HCRT

0.764

0.0002

MC4R

AGRP

0.283

NS2

MOR

NPY

0.612

0.0077

MOR

HCRT

0.283

NS

MOR

AGRP

0.034

NS

NPY

HCRT

-0.006

NS

NPY

AGRP

-0.380

NS

HCRT

AGRP

0.604

0.0051

MC4R= Melanocortin 4 Receptor; MOR= µ-Opiate Receptor; NPY= Neuropeptide
Y; HCRT= Hypocretin/Orexin; AGRP= Agouti Related Protein.
1

2

NS= not significant.
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Figure 1. Hypothalamic regulation of appetite. Pathway depicting the central
hypothalamic and peripheral neuropeptides and their sites of origin. Adapted from
Arora et al., 2006.
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Figure 2. Average Daily Feed Intake. Average daily feed intake of pigs injected
with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue bars)
prior to weaning. Raw means with SE are shown. Within a graph, means with
different letters differ (P < 0.05).
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Figure 3. Average Daily Body Weight. Average daily body weight of pigs
injected with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue
bars) prior to weaning. Raw means with SE are shown. Within a graph, means with
different letters differ (P < 0.05).
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Figure 4. Relative hypothalamic transcript abundance of µ-Opiate
Receptor. Relative hypothalamic transcript abundance of the MOR gene in pigs
injected with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue
bars). Raw means with SE are shown. Within a graph, means with different letters
differ (P < 0.05).
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Figure 5. Relative hypothalamic transcript abundance of Neuropeptide Y.
Relative hypothalamic transcript abundance of the NPY gene in pigs injected with
saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue bars). Raw
means with SE are shown. Within a graph, means with different letters differ (P <
0.05).
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Figure 6. Relative hypothalamic transcript abundance of Orexin. Relative
hypothalamic transcript abundance of the HCRT gene in pigs injected with saline
(VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue bars). Raw means
with SE are shown. Within a graph, means with different letters differ (P < 0.05).
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Figure 7. Relative hypothalamic transcript abundance of Melanocortin 4
Receptor. Relative hypothalamic transcript abundance of the MC4R gene in pigs
injected with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue
bars). Raw means with SE are shown. Within a graph, means with different letters
differ (P < 0.05).
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Figure 8. Relative hypothalamic transcript abundance of Agouti-Related
Protein. Relative hypothalamic transcript abundance of the AGRP gene in pigs
injected with saline (VEH; purple bars) or 0.05 µmol/kg syndyphalin-33 (SD-33; blue
bars). Raw means with SE are shown. Within a graph, means with different letters
differ (P < 0.05).
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Figure 9. Linear regression of µ-Opiate Receptor and Melanocortin 4
Receptor relative hypothalamic transcript abundance. Data from all
treatments across all time points are included in this analysis.
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Procedure 1. Isolation of total mRNA
1. Homogenize tissue sample in 10-20 volumes of TRI1
2. Incubate at room temperature for 5 min.
3. Centrifuge at 12,000 x g for 10 min. @ 4°C
4. Transfer supernatant to a fresh tube2
5. Add 100 µl BCP3 per 1 ml TRI
6. Mix well and incubate at room temperature for 15 min.
7.

Centrifuge at 12,000 x g for 10-15 min. @ 4°C

8. Transfer aqueous phase to a fresh tube
9. Add 500 µl isopropanol per 1 ml TRI
10. Mix well / vortex and incubate at room temperature for 10 min.
11. Centrifuge at 12,000 x g for 8 min. @ 4-25°C
12. Discard supernatant
13. Add 1 ml 75% ethanol per 1 ml TRI
14. Centrifuge at 7,500 x g for 5 min.
15. Remove ethanol and briefly dry
16. Dissolve total mRNA in buffer4
1 TRI

reagent solution (Ambion, Forest City, CA)
Repeat this step if sample contains high lipid content
3 BCP= bromochloropropane
4 50 µl H20
2
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Procedure 2. Quality/Quantity analysis of total mRNA
1. Add 1 µl mRNA and 99 µl H2O + several 100 µl H2O (blanks) to a 96 well
optically clear plate
2. Read samples at 260 nm1 and 280 nm using mass spectrometry
3. Subtract the blank value obtained from the pure H2O reading for both the
260 and 280 values
4. Obtain the quality by evaluating the 260/280 ratio2 by dividing as such
5. Obtain the quantity by multiplying (260 nm value * 40 * 100)
1 nm=
2 ideal

nanometers
260/280 ratio is 2.0

3 ng/µl
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3

Procedure 3. Removal of DNA contamination1
1. Bring all samples to 500 ng/µl concentration
2. Use 50 µl sample
3. Add 5 µl 10X TURBO DNAse Buffer and 1 µl DNAse
4. Mix by inversion
5. Incubate at 37°C for 30 min.
6. Add 5 µl re-suspended DNAse Inactivation Reagent
7. Mix well
8. Incubate at room temperature for 2 min.
9. Centrifuge at 12,000 x g for 90 sec.
10. Transfer supernatant to RNAse-free tube
1 Turbo

DNA-Free kit (Ambion, Forest City, CA)
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Procedure 4. cDNA synthesis by reverse transcription1
1. Mix to obtain a total volume of 20.0 µl
10 µl 2X Buffer
1 µl 20X Enzyme Mix
2 µl mRNA sample
7 µl nuclease-free H2O
2. Incubate reaction at 37°C for 60 min.
3. Stop reaction by heating to 95°C for 5 min.
4. Hold at 4°C
5. Store cDNA2 at -20°C
1 High

Capacity RNA-to-cDNA Kit (Applied Biosystems, Forest City, CA)
complementary DNA

2 cDNA=
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Procedure 5. Determining real-time PCR primer efficiency
1. Create a serial dilution using pooled cDNA for each primer1
2. Using standard cycling condiotions2, obtain the CT value for each dilution
point
3. Graph the log of the dilution on the X-axis and the CT value on the Y-axis
4. Connect the points with a trend line and obtain the slope of the line
5. Use the formula: 10[(1/|slope|)-1] to obtain the efficiency3
1Use

a wide dilution range ex: 1:10 – 1:100,000
in greater detail in procedure 6
3 Pfaffl, 2001
2 Explained
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Procedure 6. Real-time PCR analysis
1. Mix to obtain a total volume of 20.0 µl
10 µl Gene Expression Master Mix1
7 µl H2O
2 µl cDNA2
1 µl Primer/Probe Mix3
2. Run4 using the following parameters
2 min. at 50°C
8.5 min. at 95°C
45 Cycles of 15 sec 95°C/ 1 min. 60°C
Hold at 4°C
3. Obtain target and reference gene CT values
4. Subtract the reference gene CT from the target gene CT = Δ CT
5. Transform linearly to obtain relative expression value by using the formula:
(2- ΔCT) 5
Gene Expression Master Mix (Applied Biosystems, Forest City, CA)
Use dilutions from the linear part of the efficiency graph from procedure 5
3 Taqman Gene Expression assay primer/probe mix (Applied Biosystems, Forest
City, CA)
4 BIO-RAD iCycler
5 Livak et al., 2001
1

2
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